[Leprechaunism (Donohue syndrome)].
Fujieda
Kenji
K
Department of Pediatrics, Asahikawa Medical College.
D000015:Abnormalities, Multiple / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007223:Infant; D007328:Insulin / Q000008:administration & dosage; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000009:adverse effects; D008060:Lipodystrophy / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D009154:Mutation; D011379:Prognosis; D011972:Receptor, Insulin / Q000235:genetics; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D013577:Syndrome
D007004:Hypoglycemic Agents; D007328:Insulin; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D011972:Receptor, Insulin